PB2144: TRIAL IN PROGRESS: A PHASE 1/2 WINDOW OF OPPORTUNITY STUDY OF THE BCMAXCD3 BISPECIFIC ANTIBODY LINVOSELTAMAB IN PREVIOUSLY UNTREATED PATIENTS WITH SYMPTOMATIC MULTIPLE MYELOMA

PB2144: TRIAL IN PROGRESS: A PHASE 1/2 WINDOW OF OPPORTUNITY STUDY OF THE BCMAXCD3 BISPECIFIC ANTIBODY LINVOSELTAMAB IN PREVIOUSLY UNTREATED PATIENTS WITH SYMPTOMATIC MULTIPLE MYELOMA

Bibliographic Details
Main Authors:	Christopher J. Ferreri, Steven Quatela, Oluwaseun Aina, Pourab Roy, Anita Boyapati, Karen Rodriguez Lorenc, Glenn Kroog, Robert Z Orlowski
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000975336.52123.51

Similar Items

S197: LINKER-MM1 STUDY: LINVOSELTAMAB (REGN5458) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
by: Hans C. Lee, et al.
Published: (2023-08-01)

S189: EARLY, DEEP, AND DURABLE RESPONSES, AND LOW RATES OF CRS WITH REGN5458, A BCMAXCD3 BISPECIFIC ANTIBODY, IN A PHASE 1/2 FIRST-IN-HUMAN STUDY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
by: J. A. Zonder, et al.
Published: (2022-06-01)

PB2133: TRIAL IN PROGRESS: LINKER-MM3, A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY OF LINVOSELTAMAB VERSUS ELOTUZUMAB, POMALIDOMIDE, AND DEXAMETHASONE (EPD) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
by: Katja Weisel, et al.
Published: (2023-08-01)

مجمع الآلهة في مدينة لكش / تلو من خلال نصوص الأمير كوديا (2144-2124 ق.م)
by: فيحاء مولود علي الحيالي
Published: (2018-09-01)

Short-term Clinical Outcome of Previously Untreated and Treated Schizophrenia and Impact of Duration of Untreated Psychosis
by: Priyanka Bansal, et al.
Published: (2023-07-01)

Thalidomide in combination with vincristine, epirubicin and dexamethasone (VED) for previously untreated patients with multiple myeloma.
by: Schütt, P, et al.
Published: (2005)

Effects of the N2144S mutation on backbone dynamics of a TB-cbEGF domain pair from human fibrillin-1.
by: Yuan, X, et al.
Published: (2002)

Intraoperative radiation therapy (IORT) for previously untreated malignant gliomas
by: Takai Yoshihiro, et al.
Published: (2002-01-01)

Safety and efficacy of obinutuzumab with CHOP or bendamustine in previously untreated follicular lymphoma
by: Andrew Grigg, et al.
Published: (2017-04-01)

CHARACTERISTICS OF RENIN PROFILE AND PARAMETERS OF ARTERIAL STIFFNESS IN PATIENTS WITH PREVIOUSLY UNTREATED HYPERTENSION
by: O. A. Kravtsova, et al.
Published: (2015-09-01)

Behavioural sleep problems in previously untreated children with attention deficit hyperactivity disorder
by: Murat Eyuboglu, et al.
Published: (2018-01-01)

Considerations for shared decision management in previously untreated patients with hemophilia A or B
by: Jan Astermark, et al.
Published: (2023-04-01)

CHARACTERISTICS OF RENIN PROFILE AND PARAMETERS OF ARTERIAL STIFFNESS IN PATIENTS WITH PREVIOUSLY UNTREATED HYPERTENSION
by: O. A. Kravtsova, et al.
Published: (2015-09-01)

Spotlight on cabozantinib for previously untreated advanced renal cell carcinoma: evidence to date
by: Bersanelli M, et al.
Published: (2018-09-01)

Sputum smear positivity at two months in previously untreated pulmonary tuberculosis patients
by: Rupak Singla, et al.
Published: (2013-01-01)

Bispecific antibodies in the treatment of multiple myeloma
by: Anup Joseph Devasia, et al.
Published: (2024-09-01)

Long-term course of untreated asymptomatic esophageal eosinophilia and minimally symptomatic eosinophilic esophagitis
by: Yasuhiko Abe, et al.
Published: (2024-04-01)

First case report of M1 macrophage polarization in an untreated symptomatic patient with toxoplasmosis
by: Graziano De Luca, et al.
Published: (2018-03-01)

From Triple- to Penta-Exposed Multiple Myeloma: A Real-World Study in a Medicare Population
by: Thomas E. Delea, et al.
Published: (2024-08-01)

Bispecific antibody targets and therapies in multiple myeloma
by: Matthew Rees, et al.
Published: (2024-10-01)

PB2144: PEARL: A STUDY TO ASSESS THE EFFICACY AND SAFETY OF PENPULIMAB PLUS LENALIDOMIDE, RITUXIMAB, GEMCITABINE AND OXALIPLATIN IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA
by: X. Wei, et al.
Published: (2022-06-01)

Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth
by: Fumou Sun, et al.
Published: (2024-01-01)

Cisplatin and Irinotecan as First-Line Chemotherapy for Previously Untreated Metastatic Thymic Carcinoma: Updated Analysis
by: Akito Fukuda, et al.
Published: (2022-01-01)

Clinical outcomes of previously untreated patients with unresectable intrahepatic cholangiocarcinoma following proton beam therapy
by: Shosei Shimizu, et al.
Published: (2019-12-01)

Immunotherapy with Antibodies in Multiple Myeloma: Monoclonals, Bispecifics, and Immunoconjugates
by: Christie P. M. Verkleij, et al.
Published: (2021-03-01)

Bispecific antibodies for non-Hodgkin’s lymphomas and multiple myeloma
by: Omar Castaneda-Puglianini, et al.
Published: (2021-09-01)

Thalidomide in induction treatment increases the very good partial response rate before and after high-dose therapy in previously untreated multiple myeloma
by: Henk M. Lokhorst, et al.
Published: (2008-01-01)

A phase II trial of azacitidine with ipilimumab, nivolumab, or ipilimumab and nivolumab in previously untreated myelodysplastic syndrome
by: Ian M. Bouligny, et al.
Published: (2025-02-01)

Immunochemotherapy and Maintenance With Obinutuzumab or Rituximab in Patients With Previously Untreated Marginal Zone Lymphoma in the Randomized GALLIUM Trial
by: Michael Herold, et al.
Published: (2022-03-01)

Obinutuzumab Versus Rituximab Immunochemotherapy in Previously Untreated iNHL: Final Results From the GALLIUM Study
by: William Townsend, et al.
Published: (2023-07-01)

Bevacizumab plus chemotherapy in elderly patients with previously untreated metastatic colorectal cancer: single center experience
by: Ocvirk Janja, et al.
Published: (2016-06-01)

Role of concurrent chemoradiotherapy and stereotactic body radiation treatment for palliation of previously untreated head and neck cancers
by: Toms Vengaloor Thomas, et al.
Published: (2020-03-01)

A cross-sectional study of personality traits in women previously treated or untreated for alcohol use disorders
by: Sundh Valter, et al.
Published: (2007-08-01)

Phase II study of vemurafenib followed by ipilimumab in patients with previously untreated BRAF-mutated metastatic melanoma
by: Bin Zhang, et al.
Published: (2016-11-01)

Daratumumab in untreated newly diagnosed multiple myeloma
by: Nadine Abdallah, et al.
Published: (2019-12-01)

Bortezomib cumulative dose, efficacy, and tolerability with three different bortezomib-melphalan-prednisone regimens in previously untreated myeloma patients ineligible for high-dose therapy
by: María-Victoria Mateos, et al.
Published: (2014-06-01)

Infectious complications of bispecific antibody therapy in patients with multiple myeloma
by: Beatrice Z. Sim, et al.
Published: (2023-03-01)

Bispecific antibodies in multiple myeloma treatment: A journey in progress
by: Shih-Feng Cho, et al.
Published: (2022-10-01)

<b>History of the state-nation: of the policy of integration in latin america and Europe</b> - doi: 10.4025/dialogos.v9i2.144 <b>Histoire de l'etat-nation: de la politique d'intégration en amérique latine et en europe</b> - doi: 10.4025/dialogos.v9i2.144
by: José Gonzáles
Published: (2010-05-01)

Efficacy and safety of venetoclax-based combination therapy for previously untreated acute myeloid leukemia: a meta-analysis
by: Hongbo He, et al.
Published: (2024-12-01)